PD-1 Gene Expression Profiles for Drug Development US Patent Awarded to Vaccine and Gene Institute Florida Scientists

March 2, 2014 The Vaccine and Gene Institute of Florida (VGTI Florida) announced today that the US Patent and Trademark Office awarded VGTI Florida scientists Dr. Rafick-Pierre Sékaly, PhD and Dr. Elias Haddad, PhD U.S. Patent No. 8,647,822 titled ‘Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles.’ The PD-1 pathway (programmed cell …